ProKidney Corp.
PROK
$3.02
-$0.28-8.49%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 2.90% | 11.77% | 605.47% | -14.01% | 1.46% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -7.26% | 3.85% | 113.33% | -6.37% | 8.13% |
| Operating Income | 7.77% | -3.27% | -113.02% | 6.37% | -8.13% |
| Income Before Tax | 6.24% | -6.03% | -147.09% | -5.64% | -13.78% |
| Income Tax Expenses | 1,614.29% | 503.06% | -39.02% | -356.52% | -105.80% |
| Earnings from Continuing Operations | 3.90% | -7.41% | -123.18% | 2.23% | -10.46% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -21.37% | -17.89% | 69.79% | -25.36% | 0.99% |
| Net Income | -32.35% | -76.30% | -273.23% | -63.06% | -37.16% |
| EBIT | 7.77% | -3.27% | -113.02% | 6.37% | -8.13% |
| EBITDA | 8.48% | -2.09% | -116.78% | 7.56% | -7.28% |
| EPS Basic | 23.18% | 16.70% | -81.03% | 20.42% | -16.71% |
| Normalized Basic EPS | -166.53% | -126.32% | -123.59% | -106.00% | -64.77% |
| EPS Diluted | 23.18% | 16.70% | -81.03% | 20.42% | -16.71% |
| Normalized Diluted EPS | -166.53% | -126.32% | -123.59% | -106.00% | -64.77% |
| Average Basic Shares Outstanding | 72.22% | 111.60% | 106.25% | 104.85% | 17.57% |
| Average Diluted Shares Outstanding | 72.22% | 111.60% | 106.25% | 104.85% | 17.57% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |